Article info

Download PDFPDF
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy

Authors

  • Parvin Tajik Departments of Pathology and Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Centre; Department of Obstetrics and Gynaecology, Centre for Gynaecologic Oncology Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands; PubMed articlesGoogle scholar articles
  • Roelien van de Vrie Department of Obstetrics and Gynaecology, Centre for Gynaecologic Oncology Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands; PubMed articlesGoogle scholar articles
  • Mohammad H. Zafarmand Department of Obstetrics and Gynaecology, Centre for Gynaecologic Oncology Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands; PubMed articlesGoogle scholar articles
  • Corneel Coens The European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium; and PubMed articlesGoogle scholar articles
  • Marrije R. Buist Department of Obstetrics and Gynaecology, Centre for Gynaecologic Oncology Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands; PubMed articlesGoogle scholar articles
  • Ignace Vergote Department of Obstetrics and Gynaecology, Division of Gynaecological Oncology and Leuven Cancer Institute, University Hospitals, K. U. Leuven, Leuven, Belgium. PubMed articlesGoogle scholar articles
  • Patrick M.M. Bossuyt Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Centre; PubMed articlesGoogle scholar articles
  • Gemma G. Kenter Department of Obstetrics and Gynaecology, Centre for Gynaecologic Oncology Amsterdam, Academic Medical Centre, Amsterdam, the Netherlands; PubMed articlesGoogle scholar articles
  1. Address correspondence and reprint requests to Parvin Tajik, MD, PhD, Department of Pathology, Academic Medical Centre – University of Amsterdam, Meibergdreef 9, 1100 DD, Amsterdam, the Netherlands Room M2-106; PO Box 22660. E-mail: P.Tajik{at}amc.uva.nl.

Citation

Tajik P, van de Vrie R, Zafarmand MH, et al
The FIGO Stage IVA Versus IVB of Ovarian Cancer: Prognostic Value and Predictive Value for Neoadjuvant Chemotherapy

Publication history

  • Received June 30, 2017
  • Accepted September 28, 2017
  • First published March 1, 2018.
Online issue publication 
February 27, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.